|
|
||||||||
The Journal of Medical Microbiology, Vol 42, Issue 3 191-195, Copyright © 1995 by Society for General Microbiology
JOURNAL ARTICLE |
K. Numazaki, K. Suzuki and S. Chiba
Department of Pediatrics, School of Medicine, Sapporo Medical University, Japan.
To elucidate whether Chlamydia trachomatis and C. pneumoniae infections occur to a significant extent in monocytes-macrophages, the human monocytic cell line, U-937, was infected with C. trachomatis L2 or C. pneumoniae TW-183. Chlamydial DNA and genus-specific antigens of the lipopolysaccharides (LPS) in epitopes of the chlamydial cell wall were detected from C. trachomatis L2-inoculated monocytes over a period of 150 days after inoculation and from the C. pneumoniae TW-183-inoculated cells during a period of 14 days. C. trachomatis-infected U-937 cells expressed significantly lower levels of CD4+, CD45RA+, CD11b+ and CD33+ cells, determined by flow cytometry, than control uninoculated cells on the seventh day after inoculation and they expressed a slightly increased level of CD4+ cells and lower levels of CD45RA+ and CD11b+ cells on the 14th day after inoculation. C. pneumoniae-infected U-937 cells expressed significantly lower levels of CD4+, CD45RA+, CD11b+ and CD33+ cells than controls on the seventh day after inoculation and an increased level of CD4+ and a lower level of CD45RA+ cells on the 14th day after inoculation. Unlike infection with C. trachomatis L2 strain, chronic persistent infection with C. pneumoniae appears not to occur in monocytes-macrophages.
This article has been cited by other articles:
![]() |
A Meijer, P J M Roholl, S K Gielis-Proper, and J M Ossewaarde Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions J. Clin. Pathol., December 1, 2000; 53(12): 911 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wei, J. L. Dahl, J. W. Moulder, E. A. Roberts, P. O'Gaora, D. B. Young, and R. L. Friedman Identification of a Mycobacterium tuberculosis Gene That Enhances Mycobacterial Survival in Macrophages J. Bacteriol., January 15, 2000; 182(2): 377 - 384. [Abstract] [Full Text] |
||||
![]() |
J. T. Abrams, E. C. Vonderheid, S. Kolbe, D. M. Appelt, E. J. Arking, and B. J. Balin Sezary T-Cell Activating Factor Is a Chlamydia pneumoniae-Associated Protein Clin. Vaccine Immunol., November 1, 1999; 6(6): 895 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Taylor-Robinson, K. Numazaki, S. Chiba, and S M Tauzeeh Chlamydia pneumoniae infection and coronary heart disease BMJ, December 6, 1997; 315(7121): 1538 - 1538. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |